Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Feb 4;10(4):419–424. doi: 10.3892/mco.2019.1807

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Yokota et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 2. — CT images of the lung field and changes in serum CA19-9 levels during chemotherapy and prior to surgery. (A) Lung images prior to the initial treatment (left panel), after IP progression (middle panel), and improvements following steroid treatment (right panel). (B) The change in serum CA19-9 levels during the course of chemotherapy. CA19-9 levels were reduced markedly following 5 months of GnP therapy. At 2 months post-steroid treatment, GnP was therapy re-administered for 2 months. CT, computed tomography; CA19-9, carbohydrate antigen 19-9; IP, interstitial pneumonitis; GnP, gemcitabine plus nab-paclitaxel.